formula European HiPP
Selected indexed studies
- ESPGHAN/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4-18 years. (J Pediatr Gastroenterol Nutr, 2025) [PMID:40444524]
- Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by HIPP-Werk Georg Hipp OHG (dossier submitted by meyer.science GmbH). (EFSA J, 2022) [PMID:35281653]
- Early life gut microbiota profiles linked to synbiotic formula effects: a randomized clinical trial in European infants. (Am J Clin Nutr, 2023) [PMID:36811568]
_Worker-drafted node — pending editorial review._
Connections
formula European HiPP helps
Sources
- ESPGHAN/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4-18 years. (2025) pubmed
- Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by HIPP-Werk Georg Hipp OHG (dossier submitted by meyer.science GmbH). (2022) pubmed
- Early life gut microbiota profiles linked to synbiotic formula effects: a randomized clinical trial in European infants. (2023) pubmed
- Premastication-Review of an Infant Feeding Practice and Its Potential Impact on Allergy and Microbiome Development. (2025) pubmed
- Anthropometry and Body Composition in Childhood: Follow-Up of a Randomised, Double-Blinded Controlled Trial With a Modified, Low-Protein Infant Formula During Infancy. (2025) pubmed
- Infant formulas with synthetic oligosaccharides and respective marketing practices. (2022) pubmed
- Nutritional interventions or exposures in infants and children aged up to 3 years and their effects on subsequent risk of overweight, obesity and body fat: a systematic review of systematic reviews. (2016) pubmed
- Different infant formulas can activate toll-like receptor 9 in vitro and inhibit interleukin 6 in human primary intestinal epithelial cells. (2024) pubmed
- Pre-chewing of infant food - expectations towards an old, traditional feeding habit for potential allergy prevention. (2025) pubmed
- The infant microbiota hopscotches between community states toward maturation-longitudinal stool parameters and microbiota development in a cohort of European toddlers. (2025) pubmed